Jaundice and kernicterus in the moderately preterm infant.Clin Perinatol. 2013 Dec; 40(4):679-88.CP
Abstract
Moderate preterm infants remain at increased risk for adverse outcomes, including acute bilirubin encephalopathy (ABE). Evidence-based guidelines for management of hyperbilirubinemia in preterm infants less than 35 weeks' gestational age are not yet optimized. High concentrations of unconjugated bilirubin can cause permanent posticteric neurologic sequelae (kernicterus). Clinical manifestations of ABE in preterm infants are similar to, but often more subtle than, those of term infants. This review outlines clinical strategies to operationalize management of hyperbilirubinemia in moderately preterm infants to meet recently published consensus-based recommendations.
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
24182955
Citation
Wallenstein, Matthew B., and Vinod K. Bhutani. "Jaundice and Kernicterus in the Moderately Preterm Infant." Clinics in Perinatology, vol. 40, no. 4, 2013, pp. 679-88.
Wallenstein MB, Bhutani VK. Jaundice and kernicterus in the moderately preterm infant. Clin Perinatol. 2013;40(4):679-88.
Wallenstein, M. B., & Bhutani, V. K. (2013). Jaundice and kernicterus in the moderately preterm infant. Clinics in Perinatology, 40(4), 679-88. https://doi.org/10.1016/j.clp.2013.07.007
Wallenstein MB, Bhutani VK. Jaundice and Kernicterus in the Moderately Preterm Infant. Clin Perinatol. 2013;40(4):679-88. PubMed PMID: 24182955.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Jaundice and kernicterus in the moderately preterm infant.
AU - Wallenstein,Matthew B,
AU - Bhutani,Vinod K,
Y1 - 2013/09/20/
PY - 2013/11/5/entrez
PY - 2013/11/5/pubmed
PY - 2014/7/18/medline
KW - Bilirubin encephalopathy
KW - Bilirubin-induced neurologic dysfunction
KW - Hyperbilirubinemia
KW - Jaundice
KW - Kernicterus
KW - Moderately preterm
KW - Newborn jaundice
SP - 679
EP - 88
JF - Clinics in perinatology
JO - Clin Perinatol
VL - 40
IS - 4
N2 - Moderate preterm infants remain at increased risk for adverse outcomes, including acute bilirubin encephalopathy (ABE). Evidence-based guidelines for management of hyperbilirubinemia in preterm infants less than 35 weeks' gestational age are not yet optimized. High concentrations of unconjugated bilirubin can cause permanent posticteric neurologic sequelae (kernicterus). Clinical manifestations of ABE in preterm infants are similar to, but often more subtle than, those of term infants. This review outlines clinical strategies to operationalize management of hyperbilirubinemia in moderately preterm infants to meet recently published consensus-based recommendations.
SN - 1557-9840
UR - https://wwww.unboundmedicine.com/medline/citation/24182955/Jaundice_and_kernicterus_in_the_moderately_preterm_infant_
DB - PRIME
DP - Unbound Medicine
ER -